World's Best Scientists 2026 revealed!
Award Badge
Medicine
Austria
2026

D-Index & Metrics

Medicine

D-Index
160
Citations
111808
World Ranking
773
National Ranking
3

Research.com Recognitions

  • 2026 - Research.com Medicine in Austria Leader Award
  • 2025 - Research.com Medicine in Austria Leader Award
  • 2023 - Research.com Medicine in Austria Leader Award
  • 2022 - Research.com Medicine in Austria Leader Award
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Shahrokh F. Shariat is affiliated with the Medical University of Vienna in Austria. Their research primarily spans the field of Medicine, with a focus on subfields including Surgery, Pulmonary and Respiratory Medicine, Urology, Oncology, and Molecular Biology.

The main topics covered in Shahrokh F. Shariat's work include:

  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Urological Disorders and Treatments
  • Renal cell carcinoma treatment
  • Cancer Immunotherapy and Biomarkers

Frequent co-authors collaborating with Shahrokh F. Shariat include:

  • Pierre I. Karakiewicz (223 co-publications)
  • Alberto Briganti (190 co-publications)
  • Benjamin Pradère (178 co-publications)
  • Ekaterina Laukhtina (159 co-publications)
  • Keiichiro Mori (152 co-publications)

Shariat has published extensively in these notable venues:

  • Urologic Oncology Seminars and Original Investigations (55 publications)
  • European Urology Focus (52 publications)
  • Current Opinion in Urology (50 publications)
  • World Journal of Urology (45 publications)
  • European Urology Oncology (39 publications)

Some recent papers authored or co-authored by Shahrokh F. Shariat include:

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ), 2021, European Urology
  • Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma, 2021, New England Journal of Medicine
  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update, 2020, European Urology
  • Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update, 2023, European Urology

Shahrokh F. Shariat has received recognition as a Member of the European Academy of Sciences and Arts.

Best Publications

  • Epidemiology and risk factors of urothelial bladder cancer

    Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman

  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

    Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun

  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Eva M. Compérat;Paolo Gontero

  • Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

    Vitaly Margulis;Shahrokh F. Shariat;Surena F. Matin;Ashish M. Kamat

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Otakar Capoun;Daniel Cohen

  • Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

    Shahrokh F. Shariat;Pierre I. Karakiewicz;Ganesh S. Palapattu;Yair Lotan

  • Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Shahrokh F. Shariat;Michael J. Zelefsky;Michael W. Kattan

  • Distribution of metastatic sites in renal cell carcinoma: a population-based analysis

    M. Bianchi;M. Sun;C. Jeldres;S. F. Shariat

  • Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.

    Dean F Bajorin;J Alfred Witjes;Jürgen E Gschwend;Michael Schenker

  • Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy

    Giacomo Novara;Vincenzo Ficarra;Raymond C. Rosen;Walter Artibani

  • Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

    Jakub Dobruch;Siamak Daneshmand;Margit Fisch;Yair Lotan

  • Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy

    Giacomo Novara;Vincenzo Ficarra;Simone Mocellin;Thomas E. Ahlering

  • European guidelines on upper tract urothelial carcinomas: 2013 update.

    Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner

  • Distribution of metastatic sites in patients with prostate cancer: A population-based analysis

    Giorgio Gandaglia;Giorgio Gandaglia;Firas Abdollah;Firas Abdollah;Jonas Schiffmann;Vincent Trudeau

  • Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample

    Quoc Dien Trinh;Quoc Dien Trinh;Jesse Sammon;Maxine Sun;Praful Ravi

  • Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

    Giovanni Lughezzani;Maximilian Burger;Vitaly Margulis;Surena F. Matin

  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    Thomas Powles;Michiel S van der Heijden;Daniel Castellano;Matthew D Galsky

  • Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

    Peter R. Carroll

Frequent Co-Authors

Pierre I. Karakiewicz
Pierre I. Karakiewicz University of Montreal
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center
Maxine Sun
Maxine Sun Harvard Medical School
Paul Perrotte
Paul Perrotte University of Montreal
Fred Saad
Fred Saad University of Montreal
Markus Graefen
Markus Graefen Universität Hamburg
Morgan Rouprêt
Morgan Rouprêt Université Paris Cité
Quoc-Dien Trinh
Quoc-Dien Trinh Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As the field of medicine continues to evolve, there are a variety of related online degrees and career pathways that offer flexibility and specialized training. Many students are looking for efficient ways to advance their healthcare careers, and online programs can provide both convenience and accelerated options.

Those interested in advanced nursing may explore online dnp programs. These programs allow nurses to achieve a terminal degree faster without compromising quality. If you are seeking a more accessible route, consider researching online dnp programs that emphasize student support and flexible learning environments.

For individuals who want to start their healthcare career quickly, fast lpn program options deliver the skills needed to become a licensed practical nurse in less time. Mental health also remains a growing specialty, with programs such as pmhnp online programs helping nurses fill critical gaps in psychiatric care.

Whether you are just starting in healthcare or looking to advance, these online pathways provide accessible, accelerated options tailored to today’s diverse medical careers.

Best Scientists Citing Shahrokh F. Shariat

Trending Scientists